stars 1 stars 2 stars 3

aflo™ uses AI, sensor tech and big data to help control life-threatening symptoms for people with asthma, COPD and cystic fibrosis. Supported by funding from Innovate UK, Techstart NI and CoFund we are designing and building the next generation 'smart inhaler'. aflo™ will teach you how to inhale your medicines correctly and aggregate your data with air quality and viral data to help you to identify symptom worsening and warn of possible exacerbation risk.

Respiratory Analytics Questions

Susan Kelly is the CEO of Respiratory Analytics.

3 people are employed at Respiratory Analytics.

Top Respiratory Analytics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users